Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Artificial Light at Night and Type 2 Diabetes Mellitus
Jong-Ha Baek1,2, Yong Zhu2,3, Chandra L Jackson4,5
1Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea.
Artificial light at night (ALAN) disrupts circadian rhythms, increasing type 2 diabetes mellitus (T2DM) risk. This review explores ALAN
Area of Science:
- Chronobiology and Metabolic Health
- Environmental Health and Public Health
Background:
- Artificial light at night (ALAN) is a pervasive environmental factor disrupting natural circadian rhythms.
- ALAN exposure is increasingly linked to lifestyle-related health issues, including type 2 diabetes mellitus (T2DM).
- Existing reviews on ALAN and T2DM often overlook diverse exposure characteristics and mediating factors.
Purpose of the Study:
- To comprehensively review recent literature (2000-2024) on indoor and outdoor ALAN exposure and T2DM incidence/prevalence.
- To elucidate biological mechanisms linking ALAN to glucose metabolism dysregulation.
- To identify knowledge gaps and explore how various ALAN characteristics (type, timing, duration, wavelength, sensitivity) influence T2DM risk.
Main Methods:
- Systematic literature review of studies published between 2000 and 2024.
- Analysis of associations between diverse ALAN exposure metrics and T2DM.
- Exploration of potential mediating roles of sleep, physical activity, and diet.
Main Results:
- ALAN exposure, beyond intensity, is associated with increased T2DM risk.
- Biological pathways involving circadian disruption, hormonal imbalance, and metabolic dysfunction are implicated.
- Sleep disturbances, altered physical activity, and dietary patterns mediate the ALAN-T2DM relationship.
Conclusions:
- ALAN represents a significant environmental risk factor for T2DM.
- Understanding multifaceted ALAN characteristics is crucial for accurate risk assessment.
- Chronotherapies and chrononutrition offer potential avenues for T2DM management in the context of ALAN exposure.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Psychoneuroimmunology: Diabetes and Cancer

